Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 3/20 | 0.32 |
| ▸ | CDK4 | P11802 | 3/20 | 0.32 |
| ▸ | CCNB1 | P14635 | 3/20 | 0.32 |
| ▸ | CCNA2 | P20248 | 3/20 | 0.32 |
| ▸ | CCND1 | P24385 | 3/20 | 0.32 |
| ▸ | CDK2 | P24941 | 3/20 | 0.32 |
| ▸ | CCNA1 | P78396 | 3/20 | 0.32 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.32 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13638667 | 1.00 | CDK1 (0.32) | CDK1CDK4CCNB1CCNA2CCND1 | |
| SCHEMBL4491170 | 0.87 | KCNH2 (0.35) | CDK1CDK4CCNB1CCNA2CCND1 | |
| SCHEMBL4484036 | 0.87 | KCNH2 (0.35) | CDK1CDK4CCNB1CCNA2CCND1 | |
| SCHEMBL13638461 | 0.85 | AKT3 (0.32) | CDK1CDK4CCNB1CCNA2CCND1 | |
| SCHEMBL13638663 | 0.84 | IKBKB (0.34) | CDK1CDK4CCNB1CCNA2CCND1 | |
| SCHEMBL13638458 | 0.82 | IKBKB (0.36) | CDK1CDK4CCNB1CCNA2CCND1 | |
| SCHEMBL13638455 | 0.81 | MAPK9 (0.33) | CDK1CDK4CCNB1CCNA2CCND1 | |
| SCHEMBL13638557 | 0.81 | IKBKB (0.45) | CDK1CDK4CCNB1CCNA2CCND1 | |
| SCHEMBL13638500 | 0.81 | IKBKB (0.33) | CDK1CDK4CCNB1CCNA2CCND1 | |
| SCHEMBL14612785 | 0.80 | IKBKB (0.37) | CDK1CDK4CCNB1CCNA2CCND1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7615562-B2 | Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents | NOVARTIS AG (CH) | 2009-11-10 | — | — | US | disclosed |